OliX Pharmaceuticals, Inc (KOSDAQ:A226950) agreed to acquire 6.63% stake in PCL, Inc. (KOSDAQ:A241820) for KRW8.04 billion on November 11, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,126 KRW | +9.85% | -2.34% | -68.59% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
14,520 KRW | -2.55% | -4.47% | 181M | ||
1,126 KRW | +9.85% | -2.34% | 40.63M | ||
1st Jan change | Capi. | |
---|---|---|
-68.59% | 40.63M | |
-27.70% | 9.88B | |
+26.14% | 2.89B | |
-14.01% | 2.88B | |
-15.31% | 2.12B | |
-20.28% | 1.67B | |
+70.69% | 1.45B | |
+29.33% | 788M | |
-5.02% | 741M | |
-28.16% | 514M |
- Stock Market
- Equities
- A241820 Stock
- News PCL, Inc.
- OliX Pharmaceuticals, Inc agreed to acquire 6.63% stake in PCL, Inc. for KRW8.04 billion.